ABOUT DRUG REPURPOSING

Monoclonal antibody therapy is an additional strategy in which the therapeutic agent can be an antibody which exclusively binds to the protein around the surface area with the cancer cells.Our results also reveal the likely for any increased purpose for this metabolic therapy in areas with significant metabolic need and vulnerability to environment